|
|
 |
| A worker is seen at SK Bioscience's plant manufacturing the COVID-19 vaccine of U.S. biotech company Novavax in Andong, North Gyeongsang Province, in this photo. The Ministry of Food and Drug Safety on Wednesday authorized the use of Novavax's COVID-19 vaccine. The protein-based vaccine, Nuvaxovid, is the fifth COVID-19 vaccine to obtain approval for use here. Courtesy of SK Bioscience |
|
|
|
1 | Roland Garros 2023 |
2 | Airlines fiercely compete to acquire additional aircraft |
3 | More banks offer daily interest payments on deposits |
4 | Seoul imposes sanctions on North Korean hacking group for role in space launch |
5 | Hyundai Elevator launches AI, IoT-powered maintenance service |
6 | POSCO, GM expand joint EV battery materials investment in North America |
7 | LG Chem joins Korean firms strengthening ties with Japan |
8 | HMM tasked with preventing sale of Hyundai LNG to foreign firm |
9 | Korean stocks feared to lose steam on prolonged trade deficit, real estate doldrums |
10 | KAERI distances itself from Oxford professor's claim on Fukushima water |
1 | 'HyeMiLeeYeChaePa' producer Lee Tae-kyung hopeful of second season |
2 | How artist Michael Rakowitz resurrects lost past of Iraq through food packaging |
3 | From hardcore action to heart-throbbing romance, series to hit in June |
4![[INTERVIEW] Lee Jun-hyuk unrecognizable in 'The Roundup: No Way Out'](https://img.koreatimes.co.kr/upload/thumbnailV2/77a9da6df7da4284adbee249a87307c1.jpg/dims/resize/178/optimize) | INTERVIEWLee Jun-hyuk unrecognizable in 'The Roundup: No Way Out' |
5 | 'Elemental' director on bringing his personal story of immigration to cinema |
